Top Stories for the Week of Jan. 22nd 2007

Tuesday, January 23, 2007 12:28 PM

Top News

ACM-Pivotal Taps India's Clinical Trial Services Market

ACM-Pivotal, a central laboratory company based in Rochester, N.Y., is now providing its services in India through a central lab facility based in Mumbai. India has seen growth as an emerging region to conduct clinical trials, mostly because it has a large treatment-naïve population and highly educated investigators.

Gentiae Raises $16 million in Venture Capital

San Bruno, Calif.-based cardiac safety services company Gentiae Clinical Research has closed a $16 million round of financing with Bay City Capital and three other venture capital firms. The company’s long time investor, Three Arch Partners, along with new firms CIBC Capital Partners and Merlin Biomed Group, participated in the financing.

Other breaking news...

Company Profile: An interview with Michael Rosenberg, founder and chief executive officer, Health Decisions.

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs